0001883850-23-000037.txt : 20230207 0001883850-23-000037.hdr.sgml : 20230207 20230207161043 ACCESSION NUMBER: 0001883850-23-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230203 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 23595171 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2023-02-03 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Controller Common Stock 2023-02-03 4 M 0 5000 270.43 A 23581 D Common Stock 2023-02-03 4 F 0 3286 774.29 D 20295 D Common Stock 1779 I 2021 GRAT Common Stock 5000 I 2022 GRAT Common Stock 1480 I By 401(k) Plan Common Stock 1897 I By Trust Common Stock 461 I by Trust for Daugh Common Stock 460 I by Trust for Son Non-Qualified Stock Option (right to buy) 270.43 2023-02-03 4 M 0 5000 0.0 D 2023-12-13 Common Stock 5000 0 D These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2023-02-06